{
     "PMID": "16019082",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050920",
     "LR": "20131121",
     "IS": "0165-5728 (Print) 0165-5728 (Linking)",
     "VI": "166",
     "IP": "1-2",
     "DP": "2005 Sep",
     "TI": "Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity.",
     "PG": "19-28",
     "AB": "Excitotoxicity is a cell death caused by excessive exposure to glutamate (Glu), contributing to neuronal degeneration in many acute and chronic CNS diseases. We explored the role of fractalkine/CX3CL1 on survival of hippocampal neurons exposed to excitotoxic doses of Glu. We found that: CX3CL1 reduces excitotoxicity when co-applied with Glu, through the activation of the ERK1/2 and PI3K/Akt pathways, or administered up to 8 h after Glu insult; CX3CL1 reduces the Glu-activated whole-cell current through mechanisms dependent on intracellular Ca2+; CX3CL1 is released from hippocampal cells after excitotoxic insult, likely providing an endogenous protective mechanism against excitotoxic cell death.",
     "FAU": [
          "Limatola, Cristina",
          "Lauro, Clotilde",
          "Catalano, Myriam",
          "Ciotti, Maria Teresa",
          "Bertollini, Cristina",
          "Di Angelantonio, Silvia",
          "Ragozzino, Davide",
          "Eusebi, Fabrizio"
     ],
     "AU": [
          "Limatola C",
          "Lauro C",
          "Catalano M",
          "Ciotti MT",
          "Bertollini C",
          "Di Angelantonio S",
          "Ragozzino D",
          "Eusebi F"
     ],
     "AD": "Istituto Pasteur-Fondazione Cenci Bolognetti and Dipartimento di Fisiologia Umana e Farmacologia, Centro di Eccellenza BEMM, Universita di Roma La Sapienza, P.le A. Moro 5, I00185 Rome, Italy. cristina.limatola@uniroma1.it",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "J Neuroimmunol",
     "JT": "Journal of neuroimmunology",
     "JID": "8109498",
     "RN": [
          "0 (Chemokine CX3CL1)",
          "0 (Chemokines, CX3C)",
          "0 (Cx3cl1 protein, rat)",
          "0 (Drug Combinations)",
          "0 (Excitatory Amino Acid Agonists)",
          "0 (Membrane Proteins)",
          "0 (Neuroprotective Agents)",
          "0 (Neurotoxins)",
          "3KX376GY7L (Glutamic Acid)",
          "77521-29-0 (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Cell Survival/physiology",
          "Cells, Cultured",
          "Chemokine CX3CL1",
          "Chemokines, CX3C/administration & dosage/metabolism/pharmacology/*physiology",
          "Drug Administration Schedule",
          "Drug Combinations",
          "Electric Conductivity",
          "Excitatory Amino Acid Agonists/pharmacology",
          "Glutamic Acid/*pharmacology",
          "Hippocampus/*drug effects/*metabolism/physiology",
          "Membrane Proteins/administration & dosage/metabolism/pharmacology/*physiology",
          "Neurons/drug effects/metabolism/physiology",
          "*Neuroprotective Agents/administration & dosage/metabolism/pharmacology",
          "Neurotoxins/*pharmacology",
          "Rats",
          "Rats, Wistar",
          "alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology"
     ],
     "EDAT": "2005/07/16 09:00",
     "MHDA": "2005/09/21 09:00",
     "CRDT": [
          "2005/07/16 09:00"
     ],
     "PHST": [
          "2005/01/05 00:00 [received]",
          "2005/03/09 00:00 [accepted]",
          "2005/07/16 09:00 [pubmed]",
          "2005/09/21 09:00 [medline]",
          "2005/07/16 09:00 [entrez]"
     ],
     "AID": [
          "S0165-5728(05)00209-2 [pii]",
          "10.1016/j.jneuroim.2005.03.023 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neuroimmunol. 2005 Sep;166(1-2):19-28. doi: 10.1016/j.jneuroim.2005.03.023.",
     "term": "hippocampus"
}